Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HIV / AIDS NEWS - Page 14

Top 5 <i>Contagion</i>® News Articles for July 2017
The relationship between temperature and incidence of surgical site infections, progress towards an HIV vaccine, the cleanliness of your stethoscope, an explanation on how infection rates at Stanford Hospital are a canary in a coal mine, and an interactive visual map that depicts the HIV epidemic in the United States, make up the Top 5 news articles for the month of July 2017.
HIV Screening in Primary Care Proves Cost-Effective in Areas of High Prevalence
Introducing HIV screening in primary care offices has the potential to save lives and decrease the costs associated with treatment by increasing rates of early diagnosis.
5 New HIV Drugs in the Pipeline
In a recent editorial, Matthew Barnhart MD, MPH, medical officer for the US Agency for International Development (USAID) explored 5 new HIV drugs that are in the pipeline.
Top 5 <i>Contagion</i>® News Articles for the Week of July 23, 2017
Contagion® covered the 9th International AIDS Conference on HIV Science this week and much of the research presented at the conference made this week’s Top 5. Topics include: the successful use of oral Truvada in adolescents, a new long-acting two-drug injectable HIV regimen, and a closer look at humanized monoclonal antibody PRO 140 for HIV treatment. Additional Top 5 articles include coverage from the Biodefense World Summit, and lack of infant immunizations across the world.
Taking A Closer Look at Humanized Monoclonal Antibody PRO 140 for HIV Treatment
Nader Pourhassan, PHD, president and chief executive officer of CytoDyn, the biotechnology company that acquired PRO 140, offers insight into the antibody as treatment for HIV.
Mother-to-Child Transmission of HIV Remains a Significant Burden
Lynne Mofenson, MD, shares an update on the health burden of mother-to-child transmission (MTCT) of HIV.
How Does PrEP Affect Seroconversion After HIV is Acquired?
Due to concerns that the use of PrEP might hinder clinicians from detecting HIV in infected individuals or lead to the development of resistant strains of HIV, scientists studied how PrEP affects seroconversion after HIV is acquired.
Vaginal Ring Safe HIV Preventive Tool for Adolescents, Study Finds
A phase 2a clinical trial has found the dapivirine vaginal ring to be a safe and acceptable means for HIV prevention in adolescents, who showed notably high adherence when using the ring.
We break down our top HIV news stories of 2017. Did you read them all?